Altium Capital Management »

Western Acqstn Ventures Corp shares owned by Altium Capital Management

Quarter-by-quarter ownership of Western Acqstn Ventures Corp (WAVSW) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Western Acqstn Ventures Corp

Tip: Access up to 7 years of quarterly data

All positions including Western Acqstn Ventures Corp held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Western Acqstn Ventures Corp by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.2k 100k 0.03
2023-06-30 $6.1k 100k 0.06
2023-03-31 $8.9k 100k 0.09

More positions owned by Altium Capital Management

Cymabay Therapeutics
Immunovant Put Put Option
ImmunoGen
Astria Therapeutics (ATXS)
Xtant Med Hldgs Com New (XTNT)
Amylyx Pharmaceuticals (AMLX)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Structure Therapeutics Sponsored Ads (GPCR)
Crinetics Pharmaceuticals In (CRNX)
Xenon Pharmaceuticals (XENE)
Biohaven (BHVN)
Axsome Therapeutics (AXSM)
Karuna Therapeutics Ord
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Altium Capital Management

Top funds holding Western Acqstn Ventures Corp

Cowen And Company
Polar Securities
MMCAP International Inc. SPC
Saba Capital Management
Kim
CNH Partners
D. E. Shaw & Co
Cubist Systematic Strategies
Hudson Bay Capital Management
Weiss Asset Management LP[1
Whitebox Advisors
Rivernorth Capital Management
Wolverine Asset Management
Walleye Trading Advisors
Exos TFP Holdings

View all funds holding Western Acqstn Ventures Corp